Description
Gram-Positive Bacteria: Enterococcus, Listeria monocytogenes, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumonia, Streptococcus pyogenes
Gram-Negative Bacteria: Acinetobacter baumannii, Haemophiles influenza, Neisseria meningitides,
Pseudomonas aeruginosa, Enterobacter cloacae complex, Escherichia coli, Klebsiella oxytocic, Klebsiella pneumonia, Proteus, Serratia marcescens
Yeast:
Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis
Anti-microbial Resistance Genes: mecA ? methicillin resistance vanA/B ? vacomycin resistance KPC ? carbapenem resistance
Sample Type:Blood culture bottle
[0.2 mL of positive blood culture]
Tests Included:
Identification of bacterial or fungal pathogens in the blood using a panel of 24 different tests, which may include molecular methods, mass spectrometry, and other techniques
Sample Required:
Blood sample collected from a vein in the arm.
Test Time:
Results are typically available within a few days.
Test Range Values:
Results indicate the presence of specific pathogens, helping healthcare providers choose appropriate antibiotics for treatment.
What is the test?
The Blood Culture Identification (BCID) panel is a comprehensive set of tests used to identify bacteria or fungi in the bloodstream. It helps healthcare providers determine the causative agent of a bloodstream infection, enabling targeted antibiotic therapy.
Test Procedure:
A blood sample is collected from the patient’s arm and processed to isolate and identify the pathogens present in the bloodstream. The sample undergoes various tests, including molecular methods and mass spectrometry, to identify the specific microorganisms.
When to take the test:
The test is performed when a healthcare provider suspects a bloodstream infection based on symptoms such as fever, chills, rapid heartbeat, low blood pressure, or other signs of sepsis.
Who should take the test:
Individuals with symptoms suggestive of a bloodstream infection, especially those who are critically ill, immunocompromised, or have undergone recent invasive medical procedures, may require the Blood Culture Identification panel for accurate diagnosis and treatment.
Precautions for exceptional cases (pregnancy, etc.):
Pregnant individuals can undergo this test if necessary. Healthcare providers consider the patient’s medical history and potential risks when interpreting the results.
Frequently Asked Questions (FAQs) for Blood Culture Identification (BCID) Panel:
Q1: Why is it important to identify the specific pathogen in a bloodstream infection?
A: Identifying the causative microorganism helps healthcare providers prescribe targeted antibiotics that are effective against the specific bacteria or fungi. This approach improves treatment outcomes and reduces the risk of antibiotic resistance.
Q2: How long does it take to get the results of a BCID panel?
A: BCID panel results are typically available within a few days after the blood sample reaches the laboratory. The exact duration may vary based on the laboratory’s workload and the techniques used for identification.
Q3: Can the BCID panel detect all types of bacteria and fungi in the bloodstream?
A: The BCID panel is designed to identify a wide range of bacteria and fungi commonly associated with bloodstream infections. However, some rare or fastidious microorganisms may require specialized testing methods for detection. Healthcare providers interpret the results based on the patient’s clinical condition and symptoms.
*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.
